Andrew Gustavson is a Neurology physician. OpenAlex indexes 10 publications with 481 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
604 N Acadia Rd
Suite 411
Thibodaux, LA 703014897
Telephone
985-493-3090Registry record last updated 20 Oct 2014.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABBVIE INC.Program year20255 payments
- PFIZER INC.Program year20254 payments
- ACADIA Pharmaceuticals IncProgram year20253 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
95.4%Cholinesterase Inhibitor19%Donepezil Hcl86%Rivastigmine14%Part D<11 patientsAromatic Amino Acid Decarboxylation Inhibitor14.2%Carbidopa-Levodopa87%Carbidopa-Levodopa Er14%Part D<11 patients+ 16 more classes in this area
Musculoskeletal
2%gamma-Aminobutyric Acid-ergic Agonist1.2%Baclofen100%Part D<11 patientsCentral alpha-2 Adrenergic Agonist0.8%Tizanidine Hcl100%Part D<11 patientsCardiovascular
2%Beta blocker2%Propranolol Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Ineffective phagocytosis of amyloid-β by macrophages of Alzheimer's disease patients
Journal of Alzheimer s Disease
2005 - Dementia with parkinsonism: what is the diagnosis?
PubMed
2004 - Cholinesterase Inhibitors in Non-Alzheimer Dementias
Journal of the American Medical Directors Association
2003 - Cholinesterase Inhibitors in Non-Alzheimer Dementias
Journal of the American Medical Directors Association
2003
Similar KOLs
Other experts from the same institution or the same specialty.
Atte Meretoja
University of Helsinki
Bruce Miller, MD
University of California, San Francisco (UCSF)
Dennis Selkoe, MD
Brigham and Women's Hospital
Ettore Beghi
Mario Negri Institute for Pharmacological Research
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”